Cargando…
Surveillance of people with previously successfully treated diabetic macular oedema and proliferative diabetic retinopathy by trained ophthalmic graders: cost analysis from the EMERALD study
BACKGROUND/AIMS: Surveillance of people with previously successfully treated diabetic macular oedema (DMO) and proliferative diabetic retinopathy (PDR) adds pressure on ophthalmology services. This study evaluated a new surveillance pathway entailing multimodal imaging reviewed by trained ophthalmic...
Autores principales: | Maredza, Mandy, Mistry, Hema, Lois, Noemi, Aldington, Steve, Waugh, Norman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606536/ https://www.ncbi.nlm.nih.gov/pubmed/34083209 http://dx.doi.org/10.1136/bjophthalmol-2021-318816 |
Ejemplares similares
-
Effectiveness of Multimodal imaging for the Evaluation of Retinal oedema And new vesseLs in Diabetic retinopathy (EMERALD)
por: Lois, Noemi, et al.
Publicado: (2019) -
Evaluation of a New Model of Care for People with Complications of Diabetic Retinopathy: The EMERALD Study
por: Lois, Noemi, et al.
Publicado: (2021) -
Subthreshold micropulse laser versus standard laser for the treatment of central-involving diabetic macular oedema with central retinal thickness of <400µ: a cost-effectiveness analysis from the DIAMONDS trial
por: Mistry, Hema, et al.
Publicado: (2023) -
Patients views on a new surveillance pathway involving allied non-medical staff for people with treated diabetic macular oedema and proliferative diabetic retinopathy
por: Prior, Lindsay, et al.
Publicado: (2022) -
Diabetic retinopathy and the use of laser photocoagulation: is it cost-effective to treat early?
por: Mistry, Hema, et al.
Publicado: (2017)